2 基本信息
《第一批罕见病目录》由国家卫生健康委员会、科学技术部工业和信息化部、国家药品监督管理局、国家中医药管理局于2018年5月11日《关于公布第一批罕见病目录的通知》(国卫医发〔2018〕10号)印发。第一批罕见病目录共涉及121种疾病。
3 发布通知
关于公布第一批罕见病目录的通知
国卫医发〔2018〕10号
各省、自治区、直辖市及新疆生产建设兵团卫生计生委、科技厅(委、局)、工业和信息化主管部门、食品药品监督管理局、中医药管理局:
为贯彻落实中共中央办公厅、国务院办公厅《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》,加强我国罕见病管理,提高罕见病诊疗水平,维护罕见病患者健康权益,国家卫生健康委员会等5部门联合制定了《第一批罕见病目录》。现印发你们,供各部门在工作中参考使用。
国家卫生健康委员会 科学技术部工业和信息化部 国家药品监督管理局 国家中医药管理局
2018年5月11日
4 完整目录
序号 | 中文名称 | 英文名称 |
1 | 21-Hydroxylase Deficiency | |
2 | Albinism | |
3 | Alport 综合征 | Alport Syndrome |
4 | Amyotrophic Lateral Sclerosis | |
5 | Angelman 氏症候群(天使综合征) | Angelman Syndrome |
6 | 精氨酸酶缺乏症 | Arginase Deficiency |
7 | Asphyxiating Thoracic Dystrophy (Jeune Syndrome) | |
8 | Atypical Hemolytic Uremic Syndrome | |
9 | 自身免疫性脑炎 | Autoimmune Encephalitis |
10 | Autoimmune Hypophysitis | |
11 | Autoimmune Insulin Receptopathy (Type B insulin resistance) | |
12 | β-酮硫解酶缺乏症 | Beta-ketothiolase Deficiency |
13 | 生物素酶缺乏症 | Biotinidase Deficiency |
14 | Cardic Ion Channelopathies | |
15 | 原发性肉碱缺乏症 | Carnitine Deficiency |
16 | Castleman Disease | |
17 | Charcot-Marie-Tooth Disease | |
18 | 瓜氨酸血症 | Citrullinemia |
19 | Congenital Adrenal Hypoplasia | |
20 | Congenital Hyperinsulinemic Hypoglycemia | |
21 | Congenital Myasthenic Syndrome | |
22 | Congenital Myotonia Syndrome (Non-Dystrophic Myotonia, NDM) | |
23 | Congenital Scoliosis | |
24 | 冠状动脉扩张病 | Coronary Artery Ectasia |
25 | Diamond-Blackfan Anemia | |
26 | Erdheim-Chester病 | Erdheim-Chester Disease |
27 | 法布雷病 | Fabry Disease |
28 | Familial Mediterranean Fever | |
29 | 范可尼贫血 | Fanconi Anemia |
30 | Galactosemia | |
31 | Gaucher’s Disease | |
32 | 全身型重症肌无力 | Generalized Myasthenia Gravis |
33 | Gitelman 综合征 | Gitelman Syndrome |
34 | 戊二酸血症I型 | Glutaric Acidemia Type I |
35 | 糖原累积病(I型、Ⅱ型) | Glycogen Storage Disease (Type I、II) |
36 | Hemophilia | |
37 | Hepatolenticular Degeneration(Wilson Disease) | |
38 | Hereditary Angioedema (HAE) | |
39 | Hereditary Epidermolysis Bullosa | |
40 | Hereditary Fructose Intolerance | |
41 | Hereditary Hypomagnesemia | |
42 | Hereditary Multi-infarct Dementia (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, CADASIL) | |
43 | Hereditary Spastic Paraplegia | |
44 | 全羧化酶合成酶缺乏症 | Holocarboxylase Synthetase Deficiency |
45 | 同型半胱氨酸血症 | Homocysteinemia |
46 | Homozygous Hypercholesterolemia | |
47 | Huntington Disease | |
48 | HHH综合征 | Hyperornithinaemia-Hyperammonaemia-Homocitrullinuria Syndrome |
49 | 高苯丙氨酸血症 | Hyperphenylalaninemia |
50 | 低碱性磷酸酶血症 | Hypophosphatasia |
51 | 低磷性佝偻病 | Hypophosphatemic Rickets |
52 | 特发性心肌病 | Idiopathic Cardiomyopathy |
53 | Idiopathic Hypogonadotropic Hypogonadism | |
54 | 特发性肺动脉高压 | Idiopathic Pulmonary Arterial Hypertension |
55 | Idiopathic Pulmonary Fibrosis | |
56 | IgG4相关性疾病 | IgG4 related Disease |
57 | Inborn Errors of Bile Acid Synthesis | |
58 | 异戊酸血症 | Isovaleric Acidemia |
59 | 卡尔曼综合征 | Kallmann Syndrome |
60 | Langerhans Cell Histiocytosis | |
61 | 莱伦氏综合征 | Laron Syndrome |
62 | Leber Hereditary Optic Neuropathy | |
63 | 长链3-羟酰基辅酶A脱氢酶缺乏症 | Long Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency |
64 | Lymphangioleiomyomatosis (LAM) | |
65 | Lysinuric Protein Intolerance | |
66 | Lysosomal Acid Lipase Deficiency | |
67 | 枫糖尿症 | Maple Syrup Urine Disease |
68 | Marfan Syndrome | |
69 | McCune-Albrigh综合征 | McCune-Albright Syndrome |
70 | 中链酰基辅酶A脱氢酶缺乏症 | Medium Chain Acyl-CoA Dehydrogenase Deficiency |
71 | 甲基丙二酸血症 | Methylmalonic Academia |
72 | Mitochodrial Encephalomyopathy | |
73 | Mucopolysaccharidosis | |
74 | Multifocal Motor Neuropathy | |
75 | 多种酰基辅酶A脱氢酶缺乏症 | Multiple Acyl-CoA Dehydrogenase Deficiency |
76 | Multiple Sclerosis | |
77 | Multiple System Atrophy | |
78 | Myotonic Dystrophy | |
79 | N-乙酰谷氨酸合成酶缺乏症 | N-acetylglutamate Synthase Deficiency |
80 | Neonatal Diabetes Mellitus | |
81 | Neuromyelitis Optica | |
82 | 尼曼匹克病 | Niemann-Pick Disease |
83 | Non-Syndromic Deafness | |
84 | Noonan综合征 | Noonan Syndrome |
85 | Ornithine Transcarbamylase Deficiency | |
86 | Osteogenesis Imperfecta (Brittle Bone Disease) | |
87 | 帕金森病(青年型、早发型) | Parkinson Disease (Young-onset , Early-onset) |
88 | Paroxysmal Nocturnal Hemoglobinuria | |
89 | Peutz-Jeghers Syndrome | |
90 | Phenylketonuria | |
91 | POEMS Syndrome | |
92 | 卟啉病 | Porphyria |
93 | Prader-Willi综合征 | Prader-Willi Syndrome |
94 | Primary Combined Immune Deficiency | |
95 | Primary Hereditary Dystonia | |
96 | Primary Light Chain Amyloidosis | |
97 | 进行性家族性肝内胆汁淤积症 | Progressive Familial Intrahepatic Cholestasis |
98 | Progressive Muscular Dystrophy | |
99 | Propionic Acidemia | |
100 | Pulmonary Alveolar Proteinosis | |
101 | Pulmonary Cystic Fibrosis | |
102 | Retinitis Pigmentosa | |
103 | Retinoblastoma | |
104 | Severe Congenital Neutropenia | |
105 | Severe Myoclonic Epilepsy in Infancy (Dravet Syndrome) | |
106 | Sickle Cell Disease | |
107 | Silver-Russell综合征 | Silver-Russell Syndrome |
108 | 谷固醇血症 | Sitosterolemia |
109 | Spinal and Bulbar Muscular Atrophy (Kennedy Disease) | |
110 | Spinal Muscular Atrophy | |
111 | Spinocerebellar Ataxia | |
112 | Systemic Sclerosis | |
113 | 四氢生物蝶呤缺乏症 | Tetrahydrobiopterin Deficiency |
114 | Tuberous Sclerosis Complex | |
115 | Tyrosinemia | |
116 | 极长链酰基辅酶A脱氢酶缺乏症 | Very Long Chain Acyl-CoA Dehydrogenase Deficiency |
117 | 威廉姆斯综合征 | Williams Syndrome |
118 | Wiskott-Aldrich Syndrome | |
119 | X-linked Agammaglobulinemia | |
120 | X-连锁肾上腺脑白质营养不良 | X-linked Adrenoleukodystrophy |
121 | X-连锁淋巴增生症 | X-linked Lymphoproliferative Disease |
5 解读
为贯彻落实中共中央办公厅、国务院办公厅《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》,加强我国罕见病管理,提高罕见病诊疗水平,维护罕见病患者健康权益,近日,国家卫生健康委、科技部、工业和信息化部、国家药品监督管理局和国家中医药管理局5部门联合印发了《第一批罕见病目录》。
该目录根据我国人口疾病罹患情况、医疗技术水平、疾病负担和保障水平等,参考国际经验,由不同领域权威专家按照一定工作程序遴选产生。目录广泛征求了相关部委和行业意见并达成一致。
第一批纳入目录的罕见病共121种。未来,各部门还将按照分批制订、动态更新的工作方式,依据工作程序,逐步完善我国罕见病目录,为各部门开展相关工作提供依据,进一步维护人民群众健康权益。